Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-12-054726
Filing Date
2012-10-04
Accepted
2012-10-04 15:50:55
Documents
7
Period of Report
2012-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A v325021_10qa.htm 10-Q/A 18715
  Complete submission text file 0001144204-12-054726.txt   4965134

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT adxs-20120731.xml EX-101.INS 712337
3 XBRL TAXONOMY EXTENSION SCHEMA adxs-20120731.xsd EX-101.SCH 64274
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE adxs-20120731_cal.xml EX-101.CAL 48726
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adxs-20120731_def.xml EX-101.DEF 279876
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE adxs-20120731_lab.xml EX-101.LAB 461096
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adxs-20120731_pre.xml EX-101.PRE 347189
Mailing Address TECHNOLOGY CENTRE OF NEW JERSEY 675 ROUTE 1 NORTH BRUNSWICK NJ 08902
Business Address TECHNOLOGY CENTRE OF NEW JERSEY 675 ROUTE 1 NORTH BRUNSWICK NJ 08902 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

EIN.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-Q/A | Act: 34 | File No.: 000-28489 | Film No.: 121129577
SIC: 2834 Pharmaceutical Preparations